Spectral Price To Sales Ratio vs Ptb Ratio Analysis
| EDT Stock | CAD 0.53 0.03 6.00% |
Spectral Med financial indicator trend analysis is much more than just breaking down Spectral Med prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Spectral Med is a good investment. Please check the relationship between Spectral Med Price To Sales Ratio and its Ptb Ratio accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Spectral Med. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Price To Sales Ratio vs Ptb Ratio
Price To Sales Ratio vs Ptb Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Spectral Med Price To Sales Ratio account and Ptb Ratio. At this time, the significance of the direction appears to have no relationship.
The correlation between Spectral Med's Price To Sales Ratio and Ptb Ratio is 0.02. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Ptb Ratio in the same time period over historical financial statements of Spectral Med, assuming nothing else is changed. The correlation between historical values of Spectral Med's Price To Sales Ratio and Ptb Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Spectral Med are associated (or correlated) with its Ptb Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ptb Ratio has no effect on the direction of Price To Sales Ratio i.e., Spectral Med's Price To Sales Ratio and Ptb Ratio go up and down completely randomly.
Correlation Coefficient | 0.02 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Spectral Med stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Spectral Med sales, a figure that is much harder to manipulate than other Spectral Med multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most indicators from Spectral Med's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Spectral Med current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Spectral Med. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Spectral Med's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 24th of November 2024, Enterprise Value is likely to grow to about 130.2 M, while Selling General Administrative is likely to drop about 8.1 M.
Spectral Med fundamental ratios Correlations
Click cells to compare fundamentals
Spectral Med Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Spectral Med fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 4.0M | 8.2M | 11.6M | 12.0M | 5.2M | 5.0M | |
| Other Current Liab | 704K | 980K | 1.1M | 1.5M | 7.5M | 7.9M | |
| Total Current Liabilities | 1.1M | 2.9M | 2.3M | 4.0M | 10.2M | 10.8M | |
| Total Stockholder Equity | 2.3M | (669K) | 4.1M | (2.5M) | (16.5M) | (15.7M) | |
| Property Plant And Equipment Net | 1.1M | 1.1M | 1.1M | 701K | 893K | 1.2M | |
| Net Debt | (691K) | (5.1M) | (8.3M) | (1.8M) | 5.6M | 5.9M | |
| Retained Earnings | (80.6M) | (89.7M) | (98.5M) | (109.7M) | (125.4M) | (119.2M) | |
| Accounts Payable | 298K | 1.2M | 444K | 1.7M | 1.6M | 1.2M | |
| Cash | 1.4M | 5.8M | 8.9M | 8.4M | 3.0M | 5.8M | |
| Non Current Assets Total | 1.4M | 1.4M | 1.3M | 1.9M | 1.1M | 1.0M | |
| Cash And Short Term Investments | 1.4M | 5.8M | 8.9M | 8.4M | 3.0M | 2.8M | |
| Net Receivables | 790K | 260K | 205K | 1.1M | 186K | 176.7K | |
| Common Stock Shares Outstanding | 225.7M | 232.5M | 252.5M | 269.8M | 278.6M | 292.5M | |
| Liabilities And Stockholders Equity | 4.0M | 8.2M | 11.6M | 12.0M | 5.2M | 5.0M | |
| Non Current Liabilities Total | 667K | 5.9M | 5.2M | 10.6M | 11.5M | 12.1M | |
| Other Current Assets | 155K | 389K | 875K | 276K | 621K | 404.4K | |
| Total Liab | 1.7M | 8.8M | 7.5M | 14.5M | 21.8M | 22.8M | |
| Property Plant And Equipment Gross | 1.1M | 1.1M | 4.2M | 3.8M | 4.2M | 4.4M | |
| Total Current Assets | 2.7M | 6.8M | 10.3M | 10.1M | 4.1M | 3.9M | |
| Accumulated Other Comprehensive Income | 8.1M | 9.2M | 10.2M | 11.4M | 12.9M | 13.6M | |
| Short Term Debt | 77K | 85K | 92K | 96K | 385K | 365.8K | |
| Intangible Assets | 263K | 246K | 228K | 211K | 193K | 183.4K | |
| Non Currrent Assets Other | (1.4M) | (1.4M) | (1.3M) | (1.9M) | (1.7M) | (1.6M) | |
| Inventory | 276K | 348K | 293K | 340K | 366K | 474.6K | |
| Short Term Investments | 64K | 232K | 717K | 241K | 608K | 577.6K | |
| Common Stock Total Equity | 63.2M | 66.6M | 66.8M | 71.9M | 82.7M | 60.2M | |
| Common Stock | 66.8M | 71.9M | 84.4M | 87.1M | 87.1M | 68.9M | |
| Net Tangible Assets | 2.0M | (915K) | 3.9M | (2.7M) | (2.5M) | (2.3M) | |
| Property Plant Equipment | 1.1M | 1.1M | 1.1M | 701K | 806.2K | 807.7K | |
| Long Term Debt Total | 667K | 582K | 490K | 6.5M | 7.5M | 7.9M | |
| Net Invested Capital | 2.3M | (669K) | 4.1M | 3.6M | (8.6M) | (8.2M) | |
| Net Working Capital | 1.6M | 3.9M | 8.0M | 6.1M | (6.1M) | (5.8M) | |
| Capital Stock | 66.8M | 71.9M | 84.4M | 87.1M | 87.1M | 85.0M |
Pair Trading with Spectral Med
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spectral Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will appreciate offsetting losses from the drop in the long position's value.Moving against Spectral Stock
| 0.85 | WMT | Walmart Inc CDR | PairCorr |
| 0.77 | META | Meta Platforms CDR | PairCorr |
| 0.75 | TSLA | Tesla Inc CDR | PairCorr |
| 0.73 | AMZN | Amazon CDR | PairCorr |
| 0.71 | NVDA | NVIDIA CDR | PairCorr |
The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.
The correlation of Spectral Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spectral Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Spectral Stock
Balance Sheet is a snapshot of the financial position of Spectral Med at a specified time, usually calculated after every quarter, six months, or one year. Spectral Med Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Spectral Med and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Spectral currently owns. An asset can also be divided into two categories, current and non-current.